Heipertz W, Vontin H, Hempel V, Eichinger V
Anasth Intensivther Notfallmed. 1986 Jun;21(3):113-6.
The correlation between serum levels and degree of amnesia following 0.03 mg/kg lormetazepam or 0.02 mg/kg flunitrazepam was analysed in a prospective randomised single-blind study evaluating 20 patients with ASA classification I in each group. Blood specimens were drawn and amnesia tests performed 20, 40 and 60 min. after drug administration. The plasma level of lormetazepam was 1.8 to 2.0 times higher than that of flunitrazepam; however, the difference of lormetazepam concentrations was considerably large between the investigated individuals. There was no difference in the degree of amnesia, but also no correlation with plasma levels was measured. A serum level breakpoint for the occurrence of amnesia could not be defined.
在一项前瞻性随机单盲研究中,对每组20例ASA分级为I级的患者进行分析,以评估0.03mg/kg氯美扎酮或0.02mg/kg氟硝西泮给药后血清水平与失忆程度之间的相关性。给药后20、40和60分钟采集血样并进行失忆测试。氯美扎酮的血浆水平比氟硝西泮高1.8至2.0倍;然而,所研究个体之间氯美扎酮浓度的差异相当大。失忆程度没有差异,且未测得与血浆水平的相关性。无法确定失忆发生的血清水平断点。